Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue

https://doi.org/10.1016/0014-2999(69)90091-0Get rights and content

Abstract

The uptake of tritialted 5-hydroxytryptamine (5-HT) in slices of mouse brain was examined in vitro. A part of this uptake was inhibited by cocaine and was limited to concentrations of 5-HT below 3 × 10−6 M. This had the nature of an active uptake process. The other part was linear with the 5-HT concentration and had the nature of a partitions of 5-HT between the solution and the tissue. Reserpine reduced the accumulation of 5-HT but did not influence the rate of the initial uptake, which was strongly reduced by cocaine, imipramine and tryptamine derivatives.

In vitro, the tertiary tricyclic antidepressant agents imipramine and amitriptyline were more active than their secondary analogues desipramine and nortriptyline in inhibiting the uptake of 5-HT. In vivo, this difference was further accentuated, probably because the tertiary amines reach a higher brain concentration, this being shown to apply for imipramine compared with desipramine.

References (15)

There are more references available in the full text version of this article.

Cited by (290)

  • Cannabidiol and substance use disorder: Dream or reality

    2022, Neuropharmacology
    Citation Excerpt :

    CBD has also been shown to facilitate the neurotransmission mediated by the serotonin 1A receptor (5-HT1A). Serotonergic transmission is strongly implicated in substance abuse disorders, including addiction to substances such as cocaine, METH, amphetamine (AMPH), and morphine, which interfere with the functionality of monoamine transporters for serotonin, dopamine, and noradrenaline, leading to addiction-related behavior in humans and animals (Koe, 1976; Müller et al., 2007; Ross and Renyi, 1967, 1969). Serotoninergic neurons, which originate from the dorsal raphe nucleus (Ishimura et al., 1988), are involved in the modulation of reward-related behaviors (Luo et al., 2015; McDevitt et al., 2014).

  • The discovery of tricyclic antidepressants and their mode of action

    2022, Discoveries in Pharmacology - Volume 1 - Nervous system and hormones
  • Serotonin neurobiology in cocaine use disorder

    2020, Handbook of Behavioral Neuroscience
  • Arousal and drug abuse

    2019, Arousal in Neurological and Psychiatric Diseases
  • How do antidepressants work? New perspectives for refining future treatment approaches

    2017, The Lancet Psychiatry
    Citation Excerpt :

    The first clinically useful antidepressant medications were discovered serendipitously about 60 years ago.1 Subsequently, laboratory studies revealed that these drugs increased synaptic concentrations of serotonin and norepinephrine,2 and this action was hypothesised to underpin their antidepressant action. Decades later, a range of antidepressant drugs have been developed that, with few exceptions, act to enhance monoamine neurotransmission.

View all citing articles on Scopus
View full text